Trial Profile
Pharmacokinetics of BMS 754807 +/- a CYP3A4 inhibitor in volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 May 2014
Price :
$35
*
At a glance
- Drugs BMS 754807 (Primary) ; Ketoconazole
- Indications Breast cancer; Mycoses; Prostate cancer; Solid tumours
- Focus Pharmacokinetics
- 01 May 2014 New trial record
- 22 Mar 2014 Results presented at the 115th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.